LakeShore Biopharma
LSB
#9350
Rank
C$81.14 M
Marketcap
$4.25
Share price
9.63%
Change (1 day)
-43.22%
Change (1 year)

P/E ratio for LakeShore Biopharma (LSB)

P/E ratio at the end of 2023: -46.0

According to LakeShore Biopharma's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.67606. At the end of 2023 the company had a P/E ratio of -46.0.

P/E ratio history for LakeShore Biopharma from 2022 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2023-46.0-80.77%
2022-239

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.